Found: 17
Select item for more details and to access through your institution.
Corrigendum: Combination of rapamycin and MK-2206 induced cell death via autophagy and necroptosis in MYCN-amplified neuroblastoma cell lines.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1425039
- By:
- Publication type:
- Article
Combination of Rapamycin and MK-2206 Induced Cell Death via Autophagy and Necroptosis in MYCNAmplified Neuroblastoma Cell Lines.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2020.00031
- By:
- Publication type:
- Article
SESN1 functions as a new tumor suppressor gene via Toll‐like receptor signaling pathway in neuroblastoma.
- Published in:
- CNS Neuroscience & Therapeutics, 2024, v. 30, n. 3, p. 1, doi. 10.1111/cns.14664
- By:
- Publication type:
- Article
The role of glutamate and glutamine metabolism and related transporters in nerve cells.
- Published in:
- CNS Neuroscience & Therapeutics, 2024, v. 30, n. 2, p. 1, doi. 10.1111/cns.14617
- By:
- Publication type:
- Article
Antitumor effects of the small molecule DMAMCL in neuroblastoma via suppressing aerobic glycolysis and targeting PFKL.
- Published in:
- Cancer Cell International, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12935-021-02330-y
- By:
- Publication type:
- Article
The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1107-1
- By:
- Publication type:
- Article
Analysis and identification of novel biomarkers involved in neuroblastoma via integrated bioinformatics.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 52, doi. 10.1007/s10637-020-00980-9
- By:
- Publication type:
- Article
Proteome and Acetylome Analysis Identifies Novel Pathways and Targets Regulated by Perifosine in Neuroblastoma.
- Published in:
- Scientific Reports, 2017, p. 42062, doi. 10.1038/srep42062
- By:
- Publication type:
- Article
Combination of Rapamycin and MK-2206 Induced Cell Death via Autophagy and Necroptosis in MYCN-Amplified Neuroblastoma Cell Lines.
- Published in:
- Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2020.00031
- By:
- Publication type:
- Article
SOX4 Mediates ATRA-Induced Differentiation in Neuroblastoma Cells.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5642, doi. 10.3390/cancers14225642
- By:
- Publication type:
- Article
Correction to: Downregulation of fibronectin 1 attenuates ATRA‑induced inhibition of cell migration and invasion in neuroblastoma cells.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Downregulation of fibronectin 1 attenuates ATRA-induced inhibition of cell migration and invasion in neuroblastoma cells.
- Published in:
- Molecular & Cellular Biochemistry, 2021, v. 476, n. 10, p. 3601, doi. 10.1007/s11010-021-04113-5
- By:
- Publication type:
- Article
Downregulation of ATXN3 Enhances the Sensitivity to AKT Inhibitors (Perifosine or MK-2206), but Decreases the Sensitivity to Chemotherapeutic Drugs (Etoposide or Cisplatin) in Neuroblastoma Cells.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.686898
- By:
- Publication type:
- Article
Integrated Microarray to Identify the Hub miRNAs and Constructed miRNA–mRNA Network in Neuroblastoma Via Bioinformatics Analysis.
- Published in:
- Neurochemical Research, 2021, v. 46, n. 2, p. 197, doi. 10.1007/s11064-020-03155-3
- By:
- Publication type:
- Article
P53/PUMA are potential targets that mediate the protection of brain-derived neurotrophic factor (BDNF)/TrkB from etoposide-induced cell death in neuroblastoma (NB).
- Published in:
- Apoptosis, 2018, v. 23, n. 7/8, p. 408, doi. 10.1007/s10495-018-1467-6
- By:
- Publication type:
- Article
Prognostic Value of Pretreated Blood Inflammatory Markers in Patients with Bone Sarcoma: A Meta-Analysis.
- Published in:
- Disease Markers, 2021, p. 1, doi. 10.1155/2021/8839512
- By:
- Publication type:
- Article
FTO diversely influences sensitivity of neuroblastoma cells to various chemotherapeutic drugs.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1384141
- By:
- Publication type:
- Article